TNF-α is a key cytokine in the inflammatory response and is a potential target for therapeutic strategies related to ALI [11, 12], as it is known that patients suffering from an inflammatory response, such as rheumatoid arthritis and Crohn’s disease, will benefit from blocking TNF-α [13,14]. The gene discussed is TNF; the disease is rheumatoid arthritis.